Does low folate raise homocysteine and cause macrocytosis?

Low folate status is a primary metabolic driver of elevated plasma homocysteine levels and macrocytosis (increased mean corpuscular volume, or MCV). Folate serves as an indispensable cofactor in one-carbon metabolism, supporting both biochemical methylation and nucleic acid synthesis.

Clinical and effectiveness evidence

• Homocysteine regulation: Epidemiological and clinical trial data demonstrate an inverse relationship between serum folate levels and plasma homocysteine. When folate levels are deficient, systemic levels of 5-methyltetrahydrofolate (5-MTHF)—the primary circulating folate—drop sharply, directly resulting in hyperhomocysteinemia. Folic acid supplementation is highly effective, consistently reducing elevated homocysteine levels.
• Macrocytosis and MCV: Folate deficiency is a classic cause of macrocytic megaloblastic anemia. Clinically, this is marked by an elevated MCV (often $>100\text{ fL}$). In patients with folate-deficiency macrocytosis, oral folate supplementation induces a rapid reticulocyte response within 4 to 7 days, and MCV values typically normalize within 4 to 8 weeks as the abnormal macrocytic red blood cells are replaced.

Mechanistic explanations

• Remethylation pathway: 5-MTHF is the obligate methyl donor for the enzyme methionine synthase (MTR). MTR transfers a methyl group to homocysteine to convert it into methionine. Low folate levels deplete 5-MTHF, depriving MTR of its substrate, halting the remethylation pathway, and causing homocysteine to accumulate.
• Thymidylate synthesis failure: Folate, in the form of 5,10-methylenetetrahydrofolate, is required by thymidylate synthase to convert deoxyuridine monophosphate (dUMP) to deoxythymidine monophosphate (dTMP). Deficient folate status halts dTMP synthesis, leading to an imbalance in nucleotide pools where dUMP accumulates.
• Uracil misincorporation and apoptosis: Because of dTMP depletion, DNA polymerases misincorporate uracil into the replicating DNA of rapidly dividing erythroid precursors. DNA repair machinery attempts to excise the uracil, causing double-strand breaks, S-phase replication arrest, and apoptosis (ineffective erythropoiesis).
• Nuclear-cytoplasmic asynchrony: In surviving erythroid cells, impaired DNA replication delays nuclear maturation and division. However, cytoplasmic maturation (RNA and protein/hemoglobin synthesis) continues unaffected. This mismatch produces abnormally large erythroid precursors (megaloblasts) that enter circulation as macrocytic red blood cells.

Bottom line

• Low folate status directly raises homocysteine by halting the 5-MTHF-dependent remethylation pathway. Simultaneously, it impairs erythroid DNA replication by disrupting thymidylate synthesis, causing a nuclear-cytoplasmic mismatch that elevates mean corpuscular volume (macrocytosis). Both conditions are highly responsive to targeted folate correction.